nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP3A4—Thiotepa—urinary bladder cancer	0.039	0.347	CbGbCtD
Rotigotine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0242	0.215	CbGbCtD
Rotigotine—CYP1A2—Etoposide—urinary bladder cancer	0.0202	0.179	CbGbCtD
Rotigotine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0113	0.101	CbGbCtD
Rotigotine—CYP3A4—Etoposide—urinary bladder cancer	0.0106	0.094	CbGbCtD
Rotigotine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0072	0.0641	CbGbCtD
Rotigotine—Breast disorder—Epirubicin—urinary bladder cancer	0.00122	0.00155	CcSEcCtD
Rotigotine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00121	0.00154	CcSEcCtD
Rotigotine—Somnolence—Fluorouracil—urinary bladder cancer	0.00121	0.00154	CcSEcCtD
Rotigotine—Hypotension—Cisplatin—urinary bladder cancer	0.00121	0.00153	CcSEcCtD
Rotigotine—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.00121	0.00153	CcSEcCtD
Rotigotine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00121	0.00153	CcSEcCtD
Rotigotine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.0012	0.00152	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.0012	0.00152	CcSEcCtD
Rotigotine—Fatigue—Gemcitabine—urinary bladder cancer	0.0012	0.00152	CcSEcCtD
Rotigotine—Confusional state—Etoposide—urinary bladder cancer	0.00119	0.00152	CcSEcCtD
Rotigotine—Pain—Gemcitabine—urinary bladder cancer	0.00119	0.00151	CcSEcCtD
Rotigotine—Constipation—Gemcitabine—urinary bladder cancer	0.00119	0.00151	CcSEcCtD
Rotigotine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00118	0.0015	CcSEcCtD
Rotigotine—Asthenia—Thiotepa—urinary bladder cancer	0.00118	0.0015	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00118	0.00149	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00118	0.00149	CcSEcCtD
Rotigotine—Infection—Etoposide—urinary bladder cancer	0.00118	0.00149	CcSEcCtD
Rotigotine—Pruritus—Thiotepa—urinary bladder cancer	0.00117	0.00148	CcSEcCtD
Rotigotine—Pain—Fluorouracil—urinary bladder cancer	0.00117	0.00148	CcSEcCtD
Rotigotine—Paraesthesia—Cisplatin—urinary bladder cancer	0.00116	0.00147	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.00116	0.00147	CcSEcCtD
Rotigotine—Skin disorder—Etoposide—urinary bladder cancer	0.00115	0.00146	CcSEcCtD
Rotigotine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00115	0.00146	CcSEcCtD
Rotigotine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00114	0.00145	CcSEcCtD
Rotigotine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00114	0.00145	CcSEcCtD
Rotigotine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00114	0.00145	CcSEcCtD
Rotigotine—Breast disorder—Doxorubicin—urinary bladder cancer	0.00113	0.00143	CcSEcCtD
Rotigotine—Anorexia—Etoposide—urinary bladder cancer	0.00113	0.00143	CcSEcCtD
Rotigotine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00113	0.00143	CcSEcCtD
Rotigotine—Decreased appetite—Cisplatin—urinary bladder cancer	0.00112	0.00143	CcSEcCtD
Rotigotine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00112	0.00143	CcSEcCtD
Rotigotine—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.00112	0.00142	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00112	0.00142	CcSEcCtD
Rotigotine—Infestation NOS—Methotrexate—urinary bladder cancer	0.00111	0.00141	CcSEcCtD
Rotigotine—Infestation—Methotrexate—urinary bladder cancer	0.00111	0.00141	CcSEcCtD
Rotigotine—Depression—Methotrexate—urinary bladder cancer	0.00111	0.00141	CcSEcCtD
Rotigotine—Hypotension—Etoposide—urinary bladder cancer	0.00111	0.0014	CcSEcCtD
Rotigotine—Pain—Cisplatin—urinary bladder cancer	0.0011	0.0014	CcSEcCtD
Rotigotine—Dizziness—Thiotepa—urinary bladder cancer	0.00109	0.00138	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.00108	0.00138	CcSEcCtD
Rotigotine—Urticaria—Fluorouracil—urinary bladder cancer	0.00108	0.00137	CcSEcCtD
Rotigotine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00106	0.00135	CcSEcCtD
Rotigotine—Paraesthesia—Etoposide—urinary bladder cancer	0.00106	0.00135	CcSEcCtD
Rotigotine—Weight increased—Epirubicin—urinary bladder cancer	0.00106	0.00135	CcSEcCtD
Rotigotine—Weight decreased—Epirubicin—urinary bladder cancer	0.00106	0.00134	CcSEcCtD
Rotigotine—Somnolence—Etoposide—urinary bladder cancer	0.00105	0.00134	CcSEcCtD
Rotigotine—Vomiting—Thiotepa—urinary bladder cancer	0.00105	0.00133	CcSEcCtD
Rotigotine—Infestation NOS—Epirubicin—urinary bladder cancer	0.00104	0.00132	CcSEcCtD
Rotigotine—Infestation—Epirubicin—urinary bladder cancer	0.00104	0.00132	CcSEcCtD
Rotigotine—Rash—Thiotepa—urinary bladder cancer	0.00104	0.00132	CcSEcCtD
Rotigotine—Dermatitis—Thiotepa—urinary bladder cancer	0.00104	0.00132	CcSEcCtD
Rotigotine—Headache—Thiotepa—urinary bladder cancer	0.00103	0.00131	CcSEcCtD
Rotigotine—Decreased appetite—Etoposide—urinary bladder cancer	0.00103	0.00131	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00102	0.0013	CcSEcCtD
Rotigotine—Fatigue—Etoposide—urinary bladder cancer	0.00102	0.0013	CcSEcCtD
Rotigotine—Constipation—Etoposide—urinary bladder cancer	0.00101	0.00129	CcSEcCtD
Rotigotine—Pain—Etoposide—urinary bladder cancer	0.00101	0.00129	CcSEcCtD
Rotigotine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.001	0.00128	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.001	0.00127	CcSEcCtD
Rotigotine—Asthenia—Gemcitabine—urinary bladder cancer	0.000995	0.00126	CcSEcCtD
Rotigotine—Weight increased—Doxorubicin—urinary bladder cancer	0.000983	0.00125	CcSEcCtD
Rotigotine—Pruritus—Gemcitabine—urinary bladder cancer	0.000981	0.00125	CcSEcCtD
Rotigotine—Nausea—Thiotepa—urinary bladder cancer	0.000979	0.00124	CcSEcCtD
Rotigotine—Weight decreased—Doxorubicin—urinary bladder cancer	0.000977	0.00124	CcSEcCtD
Rotigotine—Sinusitis—Epirubicin—urinary bladder cancer	0.000976	0.00124	CcSEcCtD
Rotigotine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000976	0.00124	CcSEcCtD
Rotigotine—Pruritus—Fluorouracil—urinary bladder cancer	0.000964	0.00122	CcSEcCtD
Rotigotine—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000963	0.00122	CcSEcCtD
Rotigotine—Infestation—Doxorubicin—urinary bladder cancer	0.000963	0.00122	CcSEcCtD
Rotigotine—Visual impairment—Methotrexate—urinary bladder cancer	0.000962	0.00122	CcSEcCtD
Rotigotine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000952	0.00121	CcSEcCtD
Rotigotine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000949	0.0012	CcSEcCtD
Rotigotine—Urticaria—Etoposide—urinary bladder cancer	0.00094	0.00119	CcSEcCtD
Rotigotine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000933	0.00118	CcSEcCtD
Rotigotine—Tinnitus—Methotrexate—urinary bladder cancer	0.000931	0.00118	CcSEcCtD
Rotigotine—Asthenia—Cisplatin—urinary bladder cancer	0.000927	0.00118	CcSEcCtD
Rotigotine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00092	0.00117	CcSEcCtD
Rotigotine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000918	0.00117	CcSEcCtD
Rotigotine—Angiopathy—Methotrexate—urinary bladder cancer	0.000906	0.00115	CcSEcCtD
Rotigotine—Sinusitis—Doxorubicin—urinary bladder cancer	0.000903	0.00115	CcSEcCtD
Rotigotine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000901	0.00114	CcSEcCtD
Rotigotine—Dizziness—Fluorouracil—urinary bladder cancer	0.000901	0.00114	CcSEcCtD
Rotigotine—Visual impairment—Epirubicin—urinary bladder cancer	0.0009	0.00114	CcSEcCtD
Rotigotine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000899	0.00114	CcSEcCtD
Rotigotine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000884	0.00112	CcSEcCtD
Rotigotine—Vomiting—Gemcitabine—urinary bladder cancer	0.000881	0.00112	CcSEcCtD
Rotigotine—Mental disorder—Methotrexate—urinary bladder cancer	0.000874	0.00111	CcSEcCtD
Rotigotine—Rash—Gemcitabine—urinary bladder cancer	0.000874	0.00111	CcSEcCtD
Rotigotine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000873	0.00111	CcSEcCtD
Rotigotine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000872	0.00111	CcSEcCtD
Rotigotine—Tinnitus—Epirubicin—urinary bladder cancer	0.000871	0.00111	CcSEcCtD
Rotigotine—Erythema—Methotrexate—urinary bladder cancer	0.000869	0.0011	CcSEcCtD
Rotigotine—Malnutrition—Methotrexate—urinary bladder cancer	0.000869	0.0011	CcSEcCtD
Rotigotine—Headache—Gemcitabine—urinary bladder cancer	0.000868	0.0011	CcSEcCtD
Rotigotine—Vomiting—Fluorouracil—urinary bladder cancer	0.000867	0.0011	CcSEcCtD
Rotigotine—Rash—Fluorouracil—urinary bladder cancer	0.000859	0.00109	CcSEcCtD
Rotigotine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000859	0.00109	CcSEcCtD
Rotigotine—Headache—Fluorouracil—urinary bladder cancer	0.000854	0.00108	CcSEcCtD
Rotigotine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000851	0.00108	CcSEcCtD
Rotigotine—Asthenia—Etoposide—urinary bladder cancer	0.000849	0.00108	CcSEcCtD
Rotigotine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000849	0.00108	CcSEcCtD
Rotigotine—Angiopathy—Epirubicin—urinary bladder cancer	0.000847	0.00108	CcSEcCtD
Rotigotine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000844	0.00107	CcSEcCtD
Rotigotine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000842	0.00107	CcSEcCtD
Rotigotine—Pruritus—Etoposide—urinary bladder cancer	0.000838	0.00106	CcSEcCtD
Rotigotine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000833	0.00106	CcSEcCtD
Rotigotine—Nausea—Gemcitabine—urinary bladder cancer	0.000823	0.00105	CcSEcCtD
Rotigotine—Vomiting—Cisplatin—urinary bladder cancer	0.000822	0.00104	CcSEcCtD
Rotigotine—Mental disorder—Epirubicin—urinary bladder cancer	0.000818	0.00104	CcSEcCtD
Rotigotine—Rash—Cisplatin—urinary bladder cancer	0.000815	0.00103	CcSEcCtD
Rotigotine—Dermatitis—Cisplatin—urinary bladder cancer	0.000814	0.00103	CcSEcCtD
Rotigotine—Erythema—Epirubicin—urinary bladder cancer	0.000813	0.00103	CcSEcCtD
Rotigotine—Malnutrition—Epirubicin—urinary bladder cancer	0.000813	0.00103	CcSEcCtD
Rotigotine—Diarrhoea—Etoposide—urinary bladder cancer	0.00081	0.00103	CcSEcCtD
Rotigotine—Nausea—Fluorouracil—urinary bladder cancer	0.00081	0.00103	CcSEcCtD
Rotigotine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000806	0.00102	CcSEcCtD
Rotigotine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000806	0.00102	CcSEcCtD
Rotigotine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000784	0.000996	CcSEcCtD
Rotigotine—Malaise—Methotrexate—urinary bladder cancer	0.000783	0.000995	CcSEcCtD
Rotigotine—Dizziness—Etoposide—urinary bladder cancer	0.000783	0.000994	CcSEcCtD
Rotigotine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000782	0.000993	CcSEcCtD
Rotigotine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000781	0.000991	CcSEcCtD
Rotigotine—Vertigo—Methotrexate—urinary bladder cancer	0.000781	0.000991	CcSEcCtD
Rotigotine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000779	0.000989	CcSEcCtD
Rotigotine—Nausea—Cisplatin—urinary bladder cancer	0.000768	0.000975	CcSEcCtD
Rotigotine—Cough—Methotrexate—urinary bladder cancer	0.000758	0.000963	CcSEcCtD
Rotigotine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000757	0.000961	CcSEcCtD
Rotigotine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000754	0.000958	CcSEcCtD
Rotigotine—Vomiting—Etoposide—urinary bladder cancer	0.000753	0.000956	CcSEcCtD
Rotigotine—Erythema—Doxorubicin—urinary bladder cancer	0.000752	0.000955	CcSEcCtD
Rotigotine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000752	0.000955	CcSEcCtD
Rotigotine—Agitation—Epirubicin—urinary bladder cancer	0.000747	0.000949	CcSEcCtD
Rotigotine—Rash—Etoposide—urinary bladder cancer	0.000746	0.000948	CcSEcCtD
Rotigotine—Dermatitis—Etoposide—urinary bladder cancer	0.000746	0.000947	CcSEcCtD
Rotigotine—Headache—Etoposide—urinary bladder cancer	0.000742	0.000942	CcSEcCtD
Rotigotine—Arthralgia—Methotrexate—urinary bladder cancer	0.00074	0.000939	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000735	0.000933	CcSEcCtD
Rotigotine—Malaise—Epirubicin—urinary bladder cancer	0.000733	0.000931	CcSEcCtD
Rotigotine—Discomfort—Methotrexate—urinary bladder cancer	0.000731	0.000928	CcSEcCtD
Rotigotine—Vertigo—Epirubicin—urinary bladder cancer	0.00073	0.000927	CcSEcCtD
Rotigotine—Syncope—Epirubicin—urinary bladder cancer	0.000729	0.000926	CcSEcCtD
Rotigotine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000723	0.000918	CcSEcCtD
Rotigotine—Confusional state—Methotrexate—urinary bladder cancer	0.000715	0.000908	CcSEcCtD
Rotigotine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000715	0.000907	CcSEcCtD
Rotigotine—Cough—Epirubicin—urinary bladder cancer	0.000709	0.000901	CcSEcCtD
Rotigotine—Infection—Methotrexate—urinary bladder cancer	0.000704	0.000894	CcSEcCtD
Rotigotine—Nausea—Etoposide—urinary bladder cancer	0.000703	0.000893	CcSEcCtD
Rotigotine—Hypertension—Epirubicin—urinary bladder cancer	0.000702	0.000891	CcSEcCtD
Rotigotine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000698	0.000886	CcSEcCtD
Rotigotine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000695	0.000883	CcSEcCtD
Rotigotine—Arthralgia—Epirubicin—urinary bladder cancer	0.000692	0.000879	CcSEcCtD
Rotigotine—Agitation—Doxorubicin—urinary bladder cancer	0.000691	0.000878	CcSEcCtD
Rotigotine—Skin disorder—Methotrexate—urinary bladder cancer	0.000689	0.000874	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000687	0.000873	CcSEcCtD
Rotigotine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000685	0.00087	CcSEcCtD
Rotigotine—Discomfort—Epirubicin—urinary bladder cancer	0.000684	0.000868	CcSEcCtD
Rotigotine—Malaise—Doxorubicin—urinary bladder cancer	0.000678	0.000861	CcSEcCtD
Rotigotine—Dry mouth—Epirubicin—urinary bladder cancer	0.000677	0.00086	CcSEcCtD
Rotigotine—Vertigo—Doxorubicin—urinary bladder cancer	0.000676	0.000858	CcSEcCtD
Rotigotine—Anorexia—Methotrexate—urinary bladder cancer	0.000676	0.000858	CcSEcCtD
Rotigotine—Syncope—Doxorubicin—urinary bladder cancer	0.000675	0.000857	CcSEcCtD
Rotigotine—Confusional state—Epirubicin—urinary bladder cancer	0.000669	0.00085	CcSEcCtD
Rotigotine—Hypotension—Methotrexate—urinary bladder cancer	0.000663	0.000841	CcSEcCtD
Rotigotine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000661	0.00084	CcSEcCtD
Rotigotine—Infection—Epirubicin—urinary bladder cancer	0.000659	0.000837	CcSEcCtD
Rotigotine—Cough—Doxorubicin—urinary bladder cancer	0.000656	0.000834	CcSEcCtD
Rotigotine—Shock—Epirubicin—urinary bladder cancer	0.000653	0.000829	CcSEcCtD
Rotigotine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000651	0.000826	CcSEcCtD
Rotigotine—Hypertension—Doxorubicin—urinary bladder cancer	0.00065	0.000825	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000646	0.00082	CcSEcCtD
Rotigotine—Skin disorder—Epirubicin—urinary bladder cancer	0.000645	0.000818	CcSEcCtD
Rotigotine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000641	0.000814	CcSEcCtD
Rotigotine—Insomnia—Methotrexate—urinary bladder cancer	0.000641	0.000814	CcSEcCtD
Rotigotine—Arthralgia—Doxorubicin—urinary bladder cancer	0.00064	0.000813	CcSEcCtD
Rotigotine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000637	0.000808	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000636	0.000808	CcSEcCtD
Rotigotine—Discomfort—Doxorubicin—urinary bladder cancer	0.000633	0.000803	CcSEcCtD
Rotigotine—Anorexia—Epirubicin—urinary bladder cancer	0.000633	0.000803	CcSEcCtD
Rotigotine—Somnolence—Methotrexate—urinary bladder cancer	0.00063	0.0008	CcSEcCtD
Rotigotine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000626	0.000795	CcSEcCtD
Rotigotine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000624	0.000792	CcSEcCtD
Rotigotine—Hypotension—Epirubicin—urinary bladder cancer	0.00062	0.000787	CcSEcCtD
Rotigotine—Confusional state—Doxorubicin—urinary bladder cancer	0.000619	0.000786	CcSEcCtD
Rotigotine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000616	0.000783	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000612	0.000777	CcSEcCtD
Rotigotine—Fatigue—Methotrexate—urinary bladder cancer	0.000611	0.000776	CcSEcCtD
Rotigotine—Infection—Doxorubicin—urinary bladder cancer	0.00061	0.000774	CcSEcCtD
Rotigotine—Pain—Methotrexate—urinary bladder cancer	0.000606	0.00077	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000605	0.000768	CcSEcCtD
Rotigotine—Shock—Doxorubicin—urinary bladder cancer	0.000604	0.000767	CcSEcCtD
Rotigotine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000602	0.000764	CcSEcCtD
Rotigotine—Insomnia—Epirubicin—urinary bladder cancer	0.0006	0.000762	CcSEcCtD
Rotigotine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000596	0.000757	CcSEcCtD
Rotigotine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000596	0.000757	CcSEcCtD
Rotigotine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000594	0.000754	CcSEcCtD
Rotigotine—Somnolence—Epirubicin—urinary bladder cancer	0.00059	0.000749	CcSEcCtD
Rotigotine—Anorexia—Doxorubicin—urinary bladder cancer	0.000585	0.000743	CcSEcCtD
Rotigotine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000584	0.000742	CcSEcCtD
Rotigotine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000584	0.000742	CcSEcCtD
Rotigotine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000577	0.000732	CcSEcCtD
Rotigotine—Hypotension—Doxorubicin—urinary bladder cancer	0.000574	0.000728	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000573	0.000727	CcSEcCtD
Rotigotine—Fatigue—Epirubicin—urinary bladder cancer	0.000572	0.000726	CcSEcCtD
Rotigotine—Pain—Epirubicin—urinary bladder cancer	0.000567	0.00072	CcSEcCtD
Rotigotine—Constipation—Epirubicin—urinary bladder cancer	0.000567	0.00072	CcSEcCtD
Rotigotine—Urticaria—Methotrexate—urinary bladder cancer	0.000563	0.000715	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000559	0.00071	CcSEcCtD
Rotigotine—Insomnia—Doxorubicin—urinary bladder cancer	0.000555	0.000705	CcSEcCtD
Rotigotine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000551	0.0007	CcSEcCtD
Rotigotine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000547	0.000694	CcSEcCtD
Rotigotine—Somnolence—Doxorubicin—urinary bladder cancer	0.000546	0.000693	CcSEcCtD
Rotigotine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00054	0.000686	CcSEcCtD
Rotigotine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000534	0.000678	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00053	0.000673	CcSEcCtD
Rotigotine—Fatigue—Doxorubicin—urinary bladder cancer	0.000529	0.000672	CcSEcCtD
Rotigotine—Urticaria—Epirubicin—urinary bladder cancer	0.000527	0.000669	CcSEcCtD
Rotigotine—Pain—Doxorubicin—urinary bladder cancer	0.000525	0.000667	CcSEcCtD
Rotigotine—Constipation—Doxorubicin—urinary bladder cancer	0.000525	0.000667	CcSEcCtD
Rotigotine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000522	0.000663	CcSEcCtD
Rotigotine—Asthenia—Methotrexate—urinary bladder cancer	0.000509	0.000646	CcSEcCtD
Rotigotine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000506	0.000642	CcSEcCtD
Rotigotine—Pruritus—Methotrexate—urinary bladder cancer	0.000502	0.000637	CcSEcCtD
Rotigotine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000489	0.000621	CcSEcCtD
Rotigotine—Urticaria—Doxorubicin—urinary bladder cancer	0.000488	0.000619	CcSEcCtD
Rotigotine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000485	0.000616	CcSEcCtD
Rotigotine—Asthenia—Epirubicin—urinary bladder cancer	0.000476	0.000604	CcSEcCtD
Rotigotine—Pruritus—Epirubicin—urinary bladder cancer	0.000469	0.000596	CcSEcCtD
Rotigotine—Dizziness—Methotrexate—urinary bladder cancer	0.000469	0.000595	CcSEcCtD
Rotigotine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000454	0.000576	CcSEcCtD
Rotigotine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000452	0.000574	CcSEcCtD
Rotigotine—Vomiting—Methotrexate—urinary bladder cancer	0.000451	0.000572	CcSEcCtD
Rotigotine—Rash—Methotrexate—urinary bladder cancer	0.000447	0.000568	CcSEcCtD
Rotigotine—Dermatitis—Methotrexate—urinary bladder cancer	0.000447	0.000567	CcSEcCtD
Rotigotine—Headache—Methotrexate—urinary bladder cancer	0.000444	0.000564	CcSEcCtD
Rotigotine—Asthenia—Doxorubicin—urinary bladder cancer	0.000441	0.000559	CcSEcCtD
Rotigotine—Dizziness—Epirubicin—urinary bladder cancer	0.000439	0.000557	CcSEcCtD
Rotigotine—Pruritus—Doxorubicin—urinary bladder cancer	0.000434	0.000552	CcSEcCtD
Rotigotine—Vomiting—Epirubicin—urinary bladder cancer	0.000422	0.000536	CcSEcCtD
Rotigotine—Nausea—Methotrexate—urinary bladder cancer	0.000421	0.000535	CcSEcCtD
Rotigotine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00042	0.000533	CcSEcCtD
Rotigotine—Rash—Epirubicin—urinary bladder cancer	0.000418	0.000531	CcSEcCtD
Rotigotine—Dermatitis—Epirubicin—urinary bladder cancer	0.000418	0.000531	CcSEcCtD
Rotigotine—Headache—Epirubicin—urinary bladder cancer	0.000416	0.000528	CcSEcCtD
Rotigotine—Dizziness—Doxorubicin—urinary bladder cancer	0.000406	0.000516	CcSEcCtD
Rotigotine—Nausea—Epirubicin—urinary bladder cancer	0.000394	0.0005	CcSEcCtD
Rotigotine—Vomiting—Doxorubicin—urinary bladder cancer	0.00039	0.000496	CcSEcCtD
Rotigotine—Rash—Doxorubicin—urinary bladder cancer	0.000387	0.000492	CcSEcCtD
Rotigotine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000387	0.000491	CcSEcCtD
Rotigotine—Headache—Doxorubicin—urinary bladder cancer	0.000385	0.000488	CcSEcCtD
Rotigotine—Nausea—Doxorubicin—urinary bladder cancer	0.000365	0.000463	CcSEcCtD
Rotigotine—ADRA2B—Hemostasis—KRAS—urinary bladder cancer	4.32e-05	0.000432	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—S100B—urinary bladder cancer	4.31e-05	0.000431	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.31e-05	0.000431	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NCOR1—urinary bladder cancer	4.3e-05	0.00043	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—IL2—urinary bladder cancer	4.28e-05	0.000428	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TERT—urinary bladder cancer	4.26e-05	0.000426	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—IL2—urinary bladder cancer	4.24e-05	0.000424	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.2e-05	0.00042	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—KRAS—urinary bladder cancer	4.19e-05	0.000419	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—IL2—urinary bladder cancer	4.18e-05	0.000418	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.18e-05	0.000418	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—S100B—urinary bladder cancer	4.16e-05	0.000416	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—RHOA—urinary bladder cancer	4.09e-05	0.000409	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—RHOA—urinary bladder cancer	4.08e-05	0.000408	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—CXCL8—urinary bladder cancer	4.03e-05	0.000403	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	4.01e-05	0.000401	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—CXCL8—urinary bladder cancer	3.98e-05	0.000398	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—CXCL8—urinary bladder cancer	3.95e-05	0.000395	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—RHOA—urinary bladder cancer	3.95e-05	0.000395	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	3.93e-05	0.000393	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—FGFR3—urinary bladder cancer	3.91e-05	0.000391	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NCOR1—urinary bladder cancer	3.88e-05	0.000388	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL2—urinary bladder cancer	3.85e-05	0.000385	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—TP53—urinary bladder cancer	3.84e-05	0.000384	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TERT—urinary bladder cancer	3.84e-05	0.000384	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—RHOA—urinary bladder cancer	3.82e-05	0.000382	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—CXCL8—urinary bladder cancer	3.82e-05	0.000382	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL2—urinary bladder cancer	3.8e-05	0.00038	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—ESR1—urinary bladder cancer	3.8e-05	0.00038	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TERT—urinary bladder cancer	3.79e-05	0.000379	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—ERBB2—urinary bladder cancer	3.78e-05	0.000378	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—IL2—urinary bladder cancer	3.78e-05	0.000378	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NCOR1—urinary bladder cancer	3.74e-05	0.000374	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3.71e-05	0.000371	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3.71e-05	0.000371	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—HRAS—urinary bladder cancer	3.67e-05	0.000367	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—S100B—urinary bladder cancer	3.66e-05	0.000366	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—IL2—urinary bladder cancer	3.65e-05	0.000365	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	3.6e-05	0.00036	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—CXCL8—urinary bladder cancer	3.59e-05	0.000359	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CXCL8—urinary bladder cancer	3.58e-05	0.000358	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—HRAS—urinary bladder cancer	3.56e-05	0.000356	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—FGFR3—urinary bladder cancer	3.52e-05	0.000352	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—FGFR3—urinary bladder cancer	3.47e-05	0.000347	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—RHOA—urinary bladder cancer	3.47e-05	0.000347	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—CXCL8—urinary bladder cancer	3.47e-05	0.000347	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL2—urinary bladder cancer	3.43e-05	0.000343	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL2—urinary bladder cancer	3.42e-05	0.000342	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—ESR1—urinary bladder cancer	3.42e-05	0.000342	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TERT—urinary bladder cancer	3.42e-05	0.000342	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	3.4e-05	0.00034	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—ESR1—urinary bladder cancer	3.37e-05	0.000337	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.36e-05	0.000336	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—CXCL8—urinary bladder cancer	3.35e-05	0.000335	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CCND1—urinary bladder cancer	3.34e-05	0.000334	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CREBBP—urinary bladder cancer	3.33e-05	0.000333	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL2—urinary bladder cancer	3.31e-05	0.000331	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TERT—urinary bladder cancer	3.3e-05	0.00033	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IGF1—urinary bladder cancer	3.29e-05	0.000329	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NCOR1—urinary bladder cancer	3.29e-05	0.000329	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—EGFR—urinary bladder cancer	3.27e-05	0.000327	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MMP9—urinary bladder cancer	3.24e-05	0.000324	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CDKN1A—urinary bladder cancer	3.23e-05	0.000323	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PTEN—urinary bladder cancer	3.22e-05	0.000322	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—IL2—urinary bladder cancer	3.2e-05	0.00032	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	3.14e-05	0.000314	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	3.14e-05	0.000314	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—FGFR3—urinary bladder cancer	3.14e-05	0.000314	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.13e-05	0.000313	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—KRAS—urinary bladder cancer	3.09e-05	0.000309	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EP300—urinary bladder cancer	3.07e-05	0.000307	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	3.05e-05	0.000305	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ESR1—urinary bladder cancer	3.05e-05	0.000305	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CXCL8—urinary bladder cancer	3.04e-05	0.000304	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.04e-05	0.000304	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—FGFR3—urinary bladder cancer	3.03e-05	0.000303	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—RHOA—urinary bladder cancer	3.01e-05	0.000301	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3e-05	0.0003	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CREBBP—urinary bladder cancer	3e-05	0.0003	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.99e-05	0.000299	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—SRC—urinary bladder cancer	2.99e-05	0.000299	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IGF1—urinary bladder cancer	2.96e-05	0.000296	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CREBBP—urinary bladder cancer	2.96e-05	0.000296	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—EGFR—urinary bladder cancer	2.95e-05	0.000295	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ESR1—urinary bladder cancer	2.94e-05	0.000294	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IGF1—urinary bladder cancer	2.92e-05	0.000292	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL2—urinary bladder cancer	2.91e-05	0.000291	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—EGFR—urinary bladder cancer	2.91e-05	0.000291	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TERT—urinary bladder cancer	2.9e-05	0.00029	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—ERBB2—urinary bladder cancer	2.79e-05	0.000279	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—KRAS—urinary bladder cancer	2.78e-05	0.000278	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—KRAS—urinary bladder cancer	2.75e-05	0.000275	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—RHOA—urinary bladder cancer	2.71e-05	0.000271	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MYC—urinary bladder cancer	2.68e-05	0.000268	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—RHOA—urinary bladder cancer	2.68e-05	0.000268	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CREBBP—urinary bladder cancer	2.67e-05	0.000267	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—FGFR3—urinary bladder cancer	2.66e-05	0.000266	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CXCL8—urinary bladder cancer	2.64e-05	0.000264	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IGF1—urinary bladder cancer	2.64e-05	0.000264	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—HRAS—urinary bladder cancer	2.63e-05	0.000263	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—EGFR—urinary bladder cancer	2.62e-05	0.000262	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.62e-05	0.000262	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EGFR—urinary bladder cancer	2.62e-05	0.000262	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ESR1—urinary bladder cancer	2.58e-05	0.000258	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CREBBP—urinary bladder cancer	2.58e-05	0.000258	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IGF1—urinary bladder cancer	2.55e-05	0.000255	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.53e-05	0.000253	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—EGFR—urinary bladder cancer	2.53e-05	0.000253	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL2—urinary bladder cancer	2.53e-05	0.000253	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—ERBB2—urinary bladder cancer	2.51e-05	0.000251	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.5e-05	0.00025	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—KRAS—urinary bladder cancer	2.48e-05	0.000248	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—ERBB2—urinary bladder cancer	2.48e-05	0.000248	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—KRAS—urinary bladder cancer	2.47e-05	0.000247	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCND1—urinary bladder cancer	2.46e-05	0.000246	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.46e-05	0.000246	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.43e-05	0.000243	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.43e-05	0.000243	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—RHOA—urinary bladder cancer	2.42e-05	0.000242	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—KRAS—urinary bladder cancer	2.39e-05	0.000239	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MMP9—urinary bladder cancer	2.39e-05	0.000239	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CDKN1A—urinary bladder cancer	2.38e-05	0.000238	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CXCL8—urinary bladder cancer	2.38e-05	0.000238	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PTEN—urinary bladder cancer	2.38e-05	0.000238	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HRAS—urinary bladder cancer	2.37e-05	0.000237	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.35e-05	0.000235	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CXCL8—urinary bladder cancer	2.35e-05	0.000235	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HRAS—urinary bladder cancer	2.33e-05	0.000233	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—RHOA—urinary bladder cancer	2.33e-05	0.000233	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.32e-05	0.000232	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.29e-05	0.000229	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.29e-05	0.000229	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL2—urinary bladder cancer	2.28e-05	0.000228	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EP300—urinary bladder cancer	2.27e-05	0.000227	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CREBBP—urinary bladder cancer	2.26e-05	0.000226	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL2—urinary bladder cancer	2.24e-05	0.000224	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ERBB2—urinary bladder cancer	2.24e-05	0.000224	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IGF1—urinary bladder cancer	2.23e-05	0.000223	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EGFR—urinary bladder cancer	2.22e-05	0.000222	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCND1—urinary bladder cancer	2.22e-05	0.000222	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SRC—urinary bladder cancer	2.21e-05	0.000221	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—urinary bladder cancer	2.2e-05	0.00022	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.2e-05	0.00022	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCND1—urinary bladder cancer	2.19e-05	0.000219	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ERBB2—urinary bladder cancer	2.16e-05	0.000216	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.16e-05	0.000216	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—urinary bladder cancer	2.15e-05	0.000215	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.15e-05	0.000215	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.14e-05	0.000214	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PTEN—urinary bladder cancer	2.14e-05	0.000214	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—urinary bladder cancer	2.12e-05	0.000212	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CXCL8—urinary bladder cancer	2.12e-05	0.000212	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDKN1A—urinary bladder cancer	2.12e-05	0.000212	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	2.11e-05	0.000211	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PTEN—urinary bladder cancer	2.11e-05	0.000211	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HRAS—urinary bladder cancer	2.11e-05	0.000211	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HRAS—urinary bladder cancer	2.1e-05	0.00021	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—KRAS—urinary bladder cancer	2.1e-05	0.00021	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—RHOA—urinary bladder cancer	2.05e-05	0.000205	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CXCL8—urinary bladder cancer	2.05e-05	0.000205	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.05e-05	0.000205	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EP300—urinary bladder cancer	2.04e-05	0.000204	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HRAS—urinary bladder cancer	2.03e-05	0.000203	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.03e-05	0.000203	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL2—urinary bladder cancer	2.03e-05	0.000203	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EP300—urinary bladder cancer	2.01e-05	0.000201	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SRC—urinary bladder cancer	1.99e-05	0.000199	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MYC—urinary bladder cancer	1.98e-05	0.000198	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCND1—urinary bladder cancer	1.98e-05	0.000198	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.97e-05	0.000197	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SRC—urinary bladder cancer	1.96e-05	0.000196	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL2—urinary bladder cancer	1.96e-05	0.000196	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.96e-05	0.000196	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.94e-05	0.000194	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.94e-05	0.000194	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EGFR—urinary bladder cancer	1.93e-05	0.000193	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—urinary bladder cancer	1.92e-05	0.000192	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1A—urinary bladder cancer	1.91e-05	0.000191	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCND1—urinary bladder cancer	1.91e-05	0.000191	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PTEN—urinary bladder cancer	1.91e-05	0.000191	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	1.9e-05	0.00019	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.86e-05	0.000186	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—urinary bladder cancer	1.85e-05	0.000185	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	1.84e-05	0.000184	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PTEN—urinary bladder cancer	1.84e-05	0.000184	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.83e-05	0.000183	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KRAS—urinary bladder cancer	1.83e-05	0.000183	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EP300—urinary bladder cancer	1.82e-05	0.000182	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	1.8e-05	0.00018	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	1.79e-05	0.000179	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MYC—urinary bladder cancer	1.78e-05	0.000178	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SRC—urinary bladder cancer	1.77e-05	0.000177	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EP300—urinary bladder cancer	1.76e-05	0.000176	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MYC—urinary bladder cancer	1.76e-05	0.000176	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EGFR—urinary bladder cancer	1.74e-05	0.000174	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL2—urinary bladder cancer	1.72e-05	0.000172	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.72e-05	0.000172	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGFR—urinary bladder cancer	1.72e-05	0.000172	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SRC—urinary bladder cancer	1.71e-05	0.000171	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	1.67e-05	0.000167	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KRAS—urinary bladder cancer	1.64e-05	0.000164	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.64e-05	0.000164	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.63e-05	0.000163	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	1.63e-05	0.000163	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—urinary bladder cancer	1.62e-05	0.000162	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KRAS—urinary bladder cancer	1.62e-05	0.000162	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	1.62e-05	0.000162	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	1.62e-05	0.000162	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MYC—urinary bladder cancer	1.58e-05	0.000158	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.58e-05	0.000158	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HRAS—urinary bladder cancer	1.55e-05	0.000155	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGFR—urinary bladder cancer	1.55e-05	0.000155	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EP300—urinary bladder cancer	1.54e-05	0.000154	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MYC—urinary bladder cancer	1.53e-05	0.000153	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.52e-05	0.000152	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.5e-05	0.00015	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.5e-05	0.00015	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SRC—urinary bladder cancer	1.5e-05	0.00015	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGFR—urinary bladder cancer	1.5e-05	0.00015	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KRAS—urinary bladder cancer	1.46e-05	0.000146	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—urinary bladder cancer	1.46e-05	0.000146	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—urinary bladder cancer	1.44e-05	0.000144	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.44e-05	0.000144	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KRAS—urinary bladder cancer	1.41e-05	0.000141	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.41e-05	0.000141	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HRAS—urinary bladder cancer	1.4e-05	0.00014	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.39e-05	0.000139	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HRAS—urinary bladder cancer	1.38e-05	0.000138	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MYC—urinary bladder cancer	1.34e-05	0.000134	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.34e-05	0.000134	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.33e-05	0.000133	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	1.31e-05	0.000131	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—urinary bladder cancer	1.3e-05	0.00013	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.29e-05	0.000129	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—urinary bladder cancer	1.26e-05	0.000126	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HRAS—urinary bladder cancer	1.24e-05	0.000124	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	1.24e-05	0.000124	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HRAS—urinary bladder cancer	1.2e-05	0.00012	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.13e-05	0.000113	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—urinary bladder cancer	1.1e-05	0.00011	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.1e-05	0.00011	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.08e-05	0.000108	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.07e-05	0.000107	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	1.05e-05	0.000105	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.03e-05	0.000103	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	9.55e-06	9.55e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—EP300—urinary bladder cancer	9.11e-06	9.11e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	8.45e-06	8.45e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	7.37e-06	7.37e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—EP300—urinary bladder cancer	7.03e-06	7.03e-05	CbGpPWpGaD
